ANXA1 is an endogenous inhibitor of NF-κB that can be induced in cancer cells and experimental tumors by potent anti-inflammatory glucocorticoids and modified nonsteroidal anti-inflammatory drugs [49]. This evidence concerns the gene ANXA1 and cancer.